Delivery Order SPE2DR25D2011-SPE2DR26FADQC
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,721.55 for Quillivant XR 25 mg/5 ml suspension (150 ml) with a firm fixed price structure. The award was made on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.71 to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 150 mL quantities. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120ml quantities, valued at $1,526.88. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 1, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,550.04 to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 60 mL quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 17, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,640.47 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL). This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract will be completed by September 17, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 120 mL quantities, with a ceiling value of $1,862.76 and a firm fixed price contract type. This delivery order represents a non-set-aside, competitively awarded procurement and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 150 mL quantities, with a contract ceiling value of $2,802.86. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, with no set-aside designation applied. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance for this contract—is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,361.39 to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities, with an ultimate completion date of November 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,127.17 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL). This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to the Department of Defense medical supply chain. The contract was competitively awarded without set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.22 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of November 5, 2025. This firm fixed price delivery order, awarded on November 4, 2025, represents a competitively awarded contract with no set-aside designation. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...